The molecular mechanisms underlying myelin sheath destruction in multiple s
clerosis lesions remain unresolved. With immunogold-labeled peptides of mye
lin antigens and high-resolution microscopy, techniques that can detect ant
igen-specific antibodies in situ, we have identified autoantibodies specifi
c for the central nervous system myelin antigen myelin/oligodendrocyte glyc
oprotein. These autoantibodies were specifically bound to disintegrating my
elin around axons in lesions of acute multiple sclerosis and the marmoset m
odel of allergic encephalomyelitis. These findings represent direct evidenc
e that autoantibodies against a specific myelin protein mediate target memb
rane damage in central nervous system demyelinating disease.